Polynovo Ltd (ASX: PNV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Polynovo Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.37 billion
P/E Ratio 2,500.00
Dividend Yield 0.00%
Shares Outstanding 690.23 million
Earnings per share -0.007
Dividend per share N/A
Year To Date Return 19.03%
Earnings Yield 0.04%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Polynovo Ltd (ASX: PNV)
    Latest News

    A neon sign says 'Top Ten'.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX 200 enjoyed another top day today, nearly breaking a record high.

    Read more »

    A neon sign says 'Top Ten'.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX 200 doubled up on the gains this Tuesday, giving investors another boost.

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    Up 10%: Why the Polynovo share price is popping today

    Polynovo shares are rocketing for the second day in a row...

    Read more »

    Smiling couple looking at a phone at a bargain opportunity.
    Share Gainers

    Why Boss Energy, Cooper Energy, Judo Capital, and Polynovo shares are racing higher

    These ASX shares are catching the eye of investors on Tuesday. But why>

    Read more »

    trophy depicting top 10, asx 200 shares
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a great start to the week for ASX shares today.

    Read more »

    The Two little girls smiling upside down on a bed.
    Small Cap Shares

    'Bright outlook': 2 ASX shares ready for a massive 2024 you've not thought about

    If you buy the same old big names as everyone else, it's pretty hard to outperform.

    Read more »

    The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was another hot day on the share market this Wednesday.

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why BlueScope, Fortescue, Polynovo, and Sigma shares are racing higher

    These ASX shares are having a strong session on hump day. But why?

    Read more »

    a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
    Share Fallers

    Why Mesoblast, Navigator Global, Polynovo, and Skycity shares are falling today

    These shares are having a tough finish to the week. Why are investors selling their shares?

    Read more »

    Happy woman in purple clothes looking at asx share price on mobile phone
    Share Gainers

    Why Invictus Energy, Perpetual, Polynovo, and Zip shares are charging higher

    These ASX shares are catching the eye on Thursday. What's going on?

    Read more »

    Ten smiling business people wave to the camera after receiving some winning company news.
    Share Market News

    Here are the top 10 ASX 200 shares today

    The ASX 200 exploded higher today, with one share up more than 17%.

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Chalice Mining, Core Lithium, Perpetual, and Polynovo shares are racing higher

    These ASX shares are having a very strong session on Wednesday. But why?

    Read more »

    Frequently Asked Questions

    The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was listed on the ASX  on 26 November 1998 and is headquartered in Melbourne.

    No, the company does not historically pay dividends.

    PNV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Polynovo Ltd

    PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.

    NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.

    PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.

    PNV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    23 Feb 2024 $1.99 $0.02 1.02% 968,364 $1.98 $2.01 $1.97
    22 Feb 2024 $1.97 $0.00 0.00% 1,113,713 $1.97 $1.99 $1.94
    21 Feb 2024 $1.97 $-0.03 -1.50% 1,621,766 $1.97 $2.03 $1.97
    20 Feb 2024 $2.00 $0.03 1.53% 1,024,798 $1.96 $2.01 $1.92
    19 Feb 2024 $1.97 $-0.05 -2.48% 1,319,872 $2.00 $2.03 $1.96
    16 Feb 2024 $2.02 $0.05 2.54% 1,436,939 $2.00 $2.04 $1.98
    15 Feb 2024 $1.97 $0.04 2.08% 1,033,896 $1.99 $1.99 $1.91
    14 Feb 2024 $1.93 $-0.04 -2.03% 2,159,670 $1.93 $1.93 $1.82
    13 Feb 2024 $1.97 $0.03 1.55% 2,137,136 $1.96 $2.02 $1.95
    12 Feb 2024 $1.94 $0.02 1.04% 860,724 $1.95 $1.97 $1.93
    09 Feb 2024 $1.92 $-0.02 -1.03% 1,211,189 $1.93 $1.94 $1.89
    08 Feb 2024 $1.94 $0.01 0.52% 820,080 $1.95 $1.95 $1.91
    07 Feb 2024 $1.93 $0.05 2.67% 1,204,820 $1.91 $1.95 $1.91
    06 Feb 2024 $1.88 $0.00 0.00% 1,029,279 $1.86 $1.94 $1.85
    05 Feb 2024 $1.88 $-0.10 -5.06% 1,296,378 $1.94 $1.96 $1.88
    02 Feb 2024 $1.98 $0.11 5.88% 2,471,571 $1.90 $1.98 $1.89
    01 Feb 2024 $1.87 $-0.03 -1.57% 1,300,456 $1.87 $1.89 $1.84
    31 Jan 2024 $1.91 $0.00 0.00% 1,809,287 $1.91 $1.95 $1.88
    30 Jan 2024 $1.91 $0.08 4.37% 1,864,259 $1.84 $1.91 $1.84
    29 Jan 2024 $1.83 $0.03 1.67% 1,780,206 $1.81 $1.85 $1.78
    25 Jan 2024 $1.80 $-0.05 -2.70% 1,400,761 $1.86 $1.86 $1.78

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Oct 2023 Robyn Elliott Buy 32,000 $38,080
    On-market trade.
    28 Jun 2023 Robyn Elliott Buy 27,000 $39,690
    On-market trade.
    08 Jun 2023 David Williams Buy 22,500 $36,000
    On-market trade.
    07 Jun 2023 David Williams Buy 14,453 $23,448
    On-market trade.
    22 Mar 2023 David Williams Sell 227,653 $465,285
    On-market trade.
    21 Mar 2023 David Williams Sell 216,896 $442,986
    On-market trade.
    20 Mar 2023 David Williams Sell 305,451 $632,556
    On-market trade.
    17 Mar 2023 David Williams Sell 4,000,000 $8,160,000
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Williams Non-Executive DirectorNon-Executive Chairman Feb 2014
    Mr Williams was appointed as a Non-executive Director on 28 February 2014 and Chairman on 13 March 2014. Mr Williams is an experienced Director and investment banker with a track record in business development as well as in mergers and acquisitions and capital raising.
    Mr Bruce Rathie Non-Executive Director Feb 2010
    Mr Rathie was appointed a Director of PolyNovo on 18 February 2010. He is an experienced Company Director with a finance and legal background. He practised as a partner in a legal firm and acted as Senior Corporate Counsel to Bell Resources Limited.
    Dr Robyn Elliott Non-Executive Director Oct 2019
    Dr Elliott was appointed a Director of PolyNovo on 28 October 2019. Dr Elliott is currently Global Head, Strategic Portfolio Management at CSL Behring. Dr Elliott previously held Strategic Expansion and Quality Senior Director roles within CSL, was the Managing Director at IDT Australia and commenced her career at DBL Faulding.
    Mr Andrew Stuart Lumsden Non-Executive Director Jun 2021
    Mr Lumsden was appointed a Director of PolyNovo on 4 June 2021. He has more than 20 years' experience locally and internationally. Mr Lumsden is currently Chief Executive Officer of Wellcom Worldwide Australasia having previously held the roles of Group Chief Financial Officer and Group Chief Operating Officer.
    Mr Leon Hoare Non-Executive Director Jan 2016
    Mr Hoare was appointed a Director of PolyNovo on 27 January 2016. He is currently the Managing Director of Lohmann & Rauscher, Australia & New Zealand (ANZ), a private EU based medical device company. Previously he was Managing Director of Smith & Nephew ANZ (all divisions) until 2015. He served as President of Smith & Nephew's Asia-Pacific Advanced Wound Management (AWM) businesses for 5 years and was a member of the Global Executive Management for the AWM Division.
    Ms Christine Emmanuel-Donnelly Non-Executive Director May 2020
    Ms Emmanuel-Donnelly was appointed a Director of PolyNovo on 13 May 2020. She has more than 30 years' local and international experience. She is Vice President of the Board of the Institute of Patent and Trade Mark Attorneys of Australia on Springboard Enterprises Life Sciences Council, is a non-executive director on the board of Medical Developments International and is a member of the Australian Institute of Company Directors.
    Mr Jan-Marcel Gielen Chief Financial OfficerCompany Secretary Dec 2018
    -
    Mr Swami Raote Chief Executive Officer Jul 2022
    -
    Swami Raote Chief Executive Officer
    -
    Jan-Marcel Gielen Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 94,468,202 13.69%
    J P Morgan Nominees Australia Pty Limited 58,519,477 8.48%
    Citicorp Nominees Pty Limited 26,811,635 3.88%
    Moggs Creek Pty Ltd (Moggs Creek Super A/C) 19,010,112 2.75%
    BNP Paribas Noms Pty Ltd (Drp) 12,383,050 1.79%
    Lateral Innovations Pty Ltd (Trust A/C) 10,924,103 1.58%
    National Nominees Limited 8,413,960 1.22%
    Mr Anthony Shane Kittel + Mrs Michele Therese Kittel (Kittel Family Super A/C) 8,055,789 1.17%
    BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp) 5,909,896 0.86%
    Sandhurst Trustees Ltd (Endeavor Asset Mgmt Mda A/C) 5,739,049 0.83%
    Netwealth Investments Limited (Wrap Services A/C) 4,276,587 0.62%
    Mr Paul Gerard Brennan 4,185,095 0.61%
    Ms Simone Maree Beks 4,185,095 0.61%
    Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.59%
    Mr Matthew James Avery 3,631,338 0.53%
    Mrs Li-Hsien Tsai 3,292,698 0.48%
    Mr David Kenley 3,139,855 0.45%
    Dr Marcus James Dermot Wagstaff + Mrs Lara Kate Wagstaff 3,072,166 0.45%
    Mr Laurent Fossaert 2,929,961 0.42%
    MR CHRIS DAWBORN (HASKALI SUPER FUND A/C) 2,870,271 0.42%

    Profile

    since

    Note